Protocol No.: 160902; Phase III Study - Long-Term Tolerability and Safety of Immune Globulin Subcutaneous (IGSC) Solution Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Primary Immunode

  • Grant, J A (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/19/1012/31/14

Funding

  • Baxter Healthcare Corporation-Irvine: $6,526.00